Resyca

Resyca BV is a private, Netherlands-based company that has established itself as a specialist in innovative soft mist drug delivery platforms. Its core technologies, the PFSI™ (pre-filled syringe inhaler) and Pulmospray®/Ultra Soft Nasal Pump Spray systems, are designed to aerosolize liquid formulations—including sensitive biologics and high-dose drugs—for targeted lung and nasal cavity delivery. Operating as a B2B platform and development partner, Resyca collaborates with pharmaceutical companies to accelerate combination products to market, leveraging clinically validated, IP-protected devices that align with sustainability goals by avoiding propellants.

Proprietary soft mist inhalation and nasal spray platforms (PFSI™, Pulmospray®, Ultra Soft Nasal Pump Spray) that generate a fine, slow-moving aerosol from liquid formulations without propellants, enabling delivery of high-dose and sensitive biologics.

Resyca competes with large drug delivery companies like Aptar, Kindeva, and 3M, as well as specialists in nebulization and soft mist technologies. Its key differentiators are the high-dose/biologic capability of its syringe-based systems and its focus on partnership-driven development for complex combination products.